|
|
News Breaks | | | | January 23, 2013 | | 13:25 EDT |  | FLDM, FLDM, FLDM, GNOM, GNOM, GNOM, ILMN, ILMN, ILMN, LIFE, LIFE, LIFE, ONT, ONT, ONT, PACB, PACB, PACB | Leerink's life science tools and diagnostics analyst to hold a conference call
Life Science Tools & Diagnostics Analyst Leonard provides an update on the DNA sequencing landscape including ILMN’s new HiSeq capability, LIFE’s Ion Proton and PGM, desktop sequencing demand and the funding environment for nextgen sequencing. Relevant companies FLDM, GNOM, ILMN, LIFE, ONT and PACB may be included on the Analyst/Industry conference call to be held on January 24 at 2 pm. | |
|
News For FLDM;GNOM;ILMN;LIFE;ONT;PACB From The Last 14 Days Check below for free stories on FLDM;GNOM;ILMN;LIFE;ONT;PACB the last two weeks. |
|
|
| June 13, 2013 | | 08:01 EDT |  | LIFE | Life Technologies acquires Life Science Korea
 Subscribe for More Information | | | June 11, 2013 | | 13:34 EDT |  | LIFE | Options with increasing implied volatility: EBIX LIFE SFD
| | | June 10, 2013 | | 11:57 EDT | | LIFE | Options with increasing implied volatility: WM LIFE
| | | 07:24 EDT | | FLDM, ILMN | European Society of Human Genetics to host a conference
Subscribe for More Information | | | 06:42 EDT |  | ILMN | Illumina removed from U.S. Focus List at Credit Suisse
Subscribe for More Information | | | June 7, 2013 | | 12:04 EDT | | LIFE | Options with increasing implied volatility:TIBX RHT IRM CA LIFE
Subscribe for More Information | | | June 6, 2013 | | 08:38 EDT | | LIFE | Thermo Fisher financing slightly higher than expected, says Leerink
Leerink says Thermo Fisher's (TMO) common stock offering of $2.5B to fund the Life Technologies (LIFE) deal came in slightly above its expectation of $2.1B. Further, the firm believes the second request for information from the FTC is not a surprise, and feels any required divestitures will not materially impact the financial profile of the combined company. Leerink keeps an Outperform rating on shares of Thermo Fisher. | | | 08:31 EDT | | LIFE | Thermo Fisher expects second FTC request over Life deal
Thermo Fisher (TMO) disclosed last night that it anticipates receiving on June 7, a request for additional information and documentary material, often referred to as a "Second Request," from the United States Federal Trade Commission in connection with the FTC’s Hart-Scott-Rodino regulatory review of its Life Technologies (LIFE) acquisition. The company added that it has been working, and will continue to work, cooperatively with the FTC and that it continues to expect the acquisition to close in early 2014. | | | June 5, 2013 | | 18:48 EDT | | LIFE | On The Fly: After Hours Movers
Subscribe for More Information | | | June 4, 2013 | | 14:16 EDT | | LIFE | Unisone files patent infringement suit against Life Technologies
Subscribe for More Information | | |
|
|
|
|
|
|
